Literature DB >> 19262146

Phosphorylation of merlin regulates its stability and tumor suppressive activity.

Keqiang Ye1.   

Abstract

The neurofibromatosis-2 (NF2) tumor suppressor protein, merlin or schwannomin, inhibits cell proliferation by modulating the growth activities of its binding partners, including the cell surface glycoprotein CD44, membrane-cytoskeleton linker protein ezrin and PIKE (PI 3-kinase enhancer) GTPase, etc. Merlin exerts its growth suppressive activity through a folded conformation that is tightly controlled through phosphorylation by numerous protein kinases including PAK, PKA and Akt. Merlin inhibits PI 3-kinase activity through binding to PIKE-L. Now, we show that merlin is a physiological substrate of Akt, which phosphorylates merlin on both T230 and S315 residues. This phosphorylation abolishes the folded conformation of merlin and inhibits its association with PIKE-L, provoking merlin polyubiquitination and proteasome-mediated degradation. This finding demonstrates a negative feed-back loop from merlin/PIKE-L/PI 3-kinase to Akt in tumors- The proliferation repressive activity of merlin is also partially regulated by S518 phosphorylation- Thus, Akt-mediated merlin T230/S315 phosphorylation, combined with S518 phosphorylation by PAK and PKA, provides new insight into abrogating merlin function in the absence of merlin mutational inactivation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19262146      PMCID: PMC2634106          DOI: 10.4161/cam.1.4.5192

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  21 in total

1.  Defects in neurofibromatosis 2 protein function can arise at multiple levels.

Authors:  D H Gutmann; R T Geist; H m Xu; J S Kim; S Saporito-Irwin
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

2.  Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.

Authors:  Rong Rong; Xiaoling Tang; David H Gutmann; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-14       Impact factor: 11.205

3.  Merlin differentially associates with the microtubule and actin cytoskeleton.

Authors:  H M Xu; D H Gutmann
Journal:  J Neurosci Res       Date:  1998-02-01       Impact factor: 4.164

4.  Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins.

Authors:  L Goutebroze; E Brault; C Muchardt; J Camonis; G Thomas
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  Interdomain binding mediates tumor growth suppression by the NF2 gene product.

Authors:  L Sherman; H M Xu; R T Geist; S Saporito-Irwin; N Howells; H Ponta; P Herrlich; D H Gutmann
Journal:  Oncogene       Date:  1997-11-13       Impact factor: 9.867

6.  Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin.

Authors:  D R Scoles; D P Huynh; P A Morcos; E R Coulsell; N G Robinson; F Tamanoi; S M Pulst
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

7.  Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK.

Authors:  P I Poulikakos; G-H Xiao; R Gallagher; S Jablonski; S C Jhanwar; J R Testa
Journal:  Oncogene       Date:  2006-05-01       Impact factor: 9.867

8.  Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation.

Authors:  Xiaoling Tang; Sung-Wuk Jang; Xuerong Wang; Zhixue Liu; Scott M Bahr; Shi-Yong Sun; Daniel Brat; David H Gutmann; Keqiang Ye
Journal:  Nat Cell Biol       Date:  2007-09-23       Impact factor: 28.824

9.  Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression.

Authors:  Rong Rong; Ezequiel I Surace; Carrie A Haipek; David H Gutmann; Keqiang Ye
Journal:  Oncogene       Date:  2004-11-04       Impact factor: 9.867

10.  Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2.

Authors:  G A Rouleau; P Merel; M Lutchman; M Sanson; J Zucman; C Marineau; K Hoang-Xuan; S Demczuk; C Desmaze; B Plougastel
Journal:  Nature       Date:  1993-06-10       Impact factor: 49.962

View more
  9 in total

1.  Cdc42 regulates Schwann cell radial sorting and myelin sheath folding through NF2/merlin-dependent and independent signaling.

Authors:  Li Guo; Chandra Moon; Yi Zheng; Nancy Ratner
Journal:  Glia       Date:  2013-09-06       Impact factor: 7.452

2.  Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas.

Authors:  Abraham Jacob; Janet Oblinger; Matthew L Bush; Victoria Brendel; Griffin Santarelli; Abhik R Chaudhury; Samuel Kulp; Krista M D La Perle; Ching-Shih Chen; Long-Sheng Chang; D Bradley Welling
Journal:  Laryngoscope       Date:  2011-11-22       Impact factor: 3.325

3.  Loss of tumor suppressor Merlin in advanced breast cancer is due to post-translational regulation.

Authors:  K Adam Morrow; Shamik Das; Brandon J Metge; Keqiang Ye; Madhuri S Mulekar; J Allan Tucker; Rajeev S Samant; Lalita A Shevde
Journal:  J Biol Chem       Date:  2011-09-30       Impact factor: 5.157

4.  Merlin status regulates p75(NTR) expression and apoptotic signaling in Schwann cells following nerve injury.

Authors:  Iram Ahmad; Augusta Fernando; Richard Gurgel; J Jason Clark; Linjing Xu; Marlan R Hansen
Journal:  Neurobiol Dis       Date:  2015-06-06       Impact factor: 5.996

5.  Skeletal muscle metastasis from a gastrointestinal stromal tumor: A case report.

Authors:  Guangsheng Zhu; Wenjia Sun; Yujun Liu; Huabin Wang; Shengwei Ye
Journal:  Medicine (Baltimore)       Date:  2021-08-27       Impact factor: 1.889

6.  Rac1 controls Schwann cell myelination through cAMP and NF2/merlin.

Authors:  Li Guo; Chandra Moon; Karen Niehaus; Yi Zheng; Nancy Ratner
Journal:  J Neurosci       Date:  2012-11-28       Impact factor: 6.167

Review 7.  Role of Merlin/NF2 inactivation in tumor biology.

Authors:  A M Petrilli; C Fernández-Valle
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

Review 8.  NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations.

Authors:  Rebecca Dunbar Schroeder; Laura S Angelo; Razelle Kurzrock
Journal:  Oncotarget       Date:  2014-01-15

9.  A microtubule-LUZP1 association around tight junction promotes epithelial cell apical constriction.

Authors:  Tomoki Yano; Kazuto Tsukita; Hatsuho Kanoh; Shogo Nakayama; Hiroka Kashihara; Tomoaki Mizuno; Hiroo Tanaka; Takeshi Matsui; Yuhei Goto; Akira Komatsubara; Kazuhiro Aoki; Ryosuke Takahashi; Atsushi Tamura; Sachiko Tsukita
Journal:  EMBO J       Date:  2020-12-21       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.